Frontiers in Islet Biology and Diabetes (B3)

Frontiers in Islet Biology and Diabetes (B3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held during Feb 04 - 08, 2018 at Keystone Resort, Keystone, Colorado, United States of America.

Course Summary :
Diabetes mellitus is a pandemic disease rooted in defects of multiple organs. Autoimmune destruction of pancreatic islet beta cells (type 1 diabetes) or relentless deterioration in beta cell function from excessive systemic insulin demand (type 2 diabetes) culminates in severe or lethal metabolic derangement. Inter-organ signaling has emerged as a crucial mechanism for achieving metabolic balance, including responses by peripheral insulin-target organs that, in turn, remotely regulate islet activity. This meeting will focus on crucial aspects of beta cell biology, including islet development, pancreas cellular plasticity, beta cell surrogate generation from stem cells, novel gene editing technologies, and immune-islet interactions, as well as translation of basic discoveries into novel therapeutic trials for diabetic patients. This meeting aims to encourage the presentation of novel concepts, foster useful interactions between participants from academia and industry, and accelerate interdisciplinary approaches in diabetes research.

Additional Details will be posted as soon as they are available.